Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section now clarifies that PubMed publications are automatically populated from PubMed. The revision tag has been updated to Revision: v3.3.2, replacing the prior v3.2.0.SummaryDifference0.0%

- Check28 days agoChange DetectedTwo new trial locations were added in Tainan, Taiwan (70457 and 71004), and the entries 'Tainan City, Taiwan, 70457' and 'Tainan City, Taiwan, 71004' were removed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study record’s core details, including title, NCT number, enrollment, and locations, appear unchanged between the two screenshots. Any visible differences are limited to formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedCali, Colombia has been added as a study site and Santiago de Cali, Colombia has been removed. This changes the geographic availability for trial participation.SummaryDifference0.1%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.